RS50593B - Oktenidinske pastile protiv bolesti zapaljenja usta i ždrela - Google Patents

Oktenidinske pastile protiv bolesti zapaljenja usta i ždrela

Info

Publication number
RS50593B
RS50593B RSP-2008/0346A RSP20080346A RS50593B RS 50593 B RS50593 B RS 50593B RS P20080346 A RSP20080346 A RS P20080346A RS 50593 B RS50593 B RS 50593B
Authority
RS
Serbia
Prior art keywords
used against
octenidine
oral
pharyngeal
against inflammatory
Prior art date
Application number
RSP-2008/0346A
Other languages
English (en)
Inventor
Holger Miething
Original Assignee
Divapharma Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Divapharma Gmbh. filed Critical Divapharma Gmbh.
Publication of RS50593B publication Critical patent/RS50593B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Farmaceutska kompozicija, naznačena time, da je u formi čvrstih tableta za rastvaranje u ustima, posebno pastila, za lokalno uspešno lečenje bolesti zapaljenja usne šupljine i ždrela, gde kompozicija uključuje terapeutski efikasnu količinu oktenidina. Prijava sadrži 1+23 patentnih zahteva.
RSP-2008/0346A 2004-10-12 2005-08-19 Oktenidinske pastile protiv bolesti zapaljenja usta i ždrela RS50593B (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004049798 2004-10-12
DE102004052308A DE102004052308B4 (de) 2004-10-12 2004-10-28 Octenidinhaltige Lutschtabletten gegen entzündliche Erkrankungen des Mund- und Rachenraums
PCT/EP2005/008973 WO2006039961A1 (de) 2004-10-12 2005-08-19 Octenidinhaltige lutschtabletten gegen entzündliche erkrankungen des mund- und rachenraums

Publications (1)

Publication Number Publication Date
RS50593B true RS50593B (sr) 2010-05-07

Family

ID=35149087

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2008/0346A RS50593B (sr) 2004-10-12 2005-08-19 Oktenidinske pastile protiv bolesti zapaljenja usta i ždrela

Country Status (15)

Country Link
EP (1) EP1799186B1 (sr)
CN (1) CN101052373B (sr)
AT (1) ATE398441T1 (sr)
DE (2) DE102004052308B4 (sr)
EA (1) EA011991B1 (sr)
ES (1) ES2309790T3 (sr)
GE (1) GEP20094809B (sr)
HK (1) HK1108835A1 (sr)
HR (1) HRP20080438T3 (sr)
NO (1) NO20071795L (sr)
PL (1) PL1799186T3 (sr)
RS (1) RS50593B (sr)
SI (1) SI1799186T1 (sr)
UA (1) UA83320C2 (sr)
WO (1) WO2006039961A1 (sr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0819231B8 (pt) 2007-10-31 2021-05-25 Mcneil Ppc Inc processo para preparo de forma farmacêutica de desintegração rápida por moldagem a quente na presença de sal inorgânico hidratado
AU2009298411B2 (en) 2008-10-02 2013-06-06 Mylan Inc. Method of making a multilayer adhesive laminate
EP2201951A1 (de) * 2008-11-14 2010-06-30 Ahmet Melih Aydinoglu Octenidin-Zusammensetzung
US8343533B2 (en) 2009-09-24 2013-01-01 Mcneil-Ppc, Inc. Manufacture of lozenge product with radiofrequency
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
PL3284459T3 (pl) 2011-04-29 2021-06-28 Moberg Pharma Ab Kompozycje farmaceutyczne zawierające środek miejscowo znieczulający, taki jak bupiwakaina, do podawania miejscowego do jamy ustnej lub gardła
DE102012000976A1 (de) * 2012-01-20 2013-07-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die topische Behandlung
DE102012007212A1 (de) 2012-04-11 2013-10-17 Merz Pharma Gmbh & Co. Kgaa Zubereitung zur topischen Anwendung auf Schleimhäuten mit Polyhexanid als Wirkstoff
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
DE202013000446U1 (de) * 2012-10-04 2013-10-07 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung, insbesondere pharmazeutische Zusammensetzung, insbesondere zur Verabreichung bei Heiserkeit und Halsschmerzen
JP6505721B2 (ja) 2014-01-10 2019-04-24 ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッド 高周波及び損失性被覆粒子を使用した錠剤の製造プロセス
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210386A (en) * 1983-12-09 1987-11-27 Sterling Drug Inc Saccharine salts and dentrifice compositions
WO1987005501A1 (en) * 1986-03-17 1987-09-24 Oral Research Laboratories, Inc. Treatment of dental surfaces with plaque retardants
GB9204410D0 (en) * 1992-02-29 1992-04-15 Smithkline Beecham Plc Method of treatment
US6350438B1 (en) * 1998-02-27 2002-02-26 The Procter & Gamble Company Oral care compositions comprising chlorite and methods
DE10026716A1 (de) * 2000-05-30 2001-12-13 Ferton Holding Sa Prophylaktische Mundspüllösung
PT1294383E (pt) * 2000-06-30 2008-10-08 Procter & Gamble Composições orais compreendendo agentes antimicrobianos
DE10205883A1 (de) * 2002-02-13 2003-08-21 Schuelke & Mayr Gmbh Wässriges Antiseptikum auf Basis von Bispyridiniumalkanen

Also Published As

Publication number Publication date
EA011991B1 (ru) 2009-06-30
UA83320C2 (ru) 2008-06-25
WO2006039961A1 (de) 2006-04-20
GEP20094809B (en) 2009-10-26
DE102004052308B4 (de) 2013-04-04
SI1799186T1 (sl) 2008-10-31
CN101052373B (zh) 2010-06-16
CN101052373A (zh) 2007-10-10
EP1799186B1 (de) 2008-06-18
DE502005004475D1 (de) 2008-07-31
DE102004052308A1 (de) 2006-04-13
EA200700777A1 (ru) 2007-10-26
ATE398441T1 (de) 2008-07-15
EP1799186A1 (de) 2007-06-27
HRP20080438T3 (en) 2008-10-31
ES2309790T3 (es) 2008-12-16
NO20071795L (no) 2007-07-06
HK1108835A1 (en) 2008-05-23
PL1799186T3 (pl) 2008-11-28

Similar Documents

Publication Publication Date Title
RS50593B (sr) Oktenidinske pastile protiv bolesti zapaljenja usta i ždrela
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
SG169233A1 (en) Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
RS20090105A (en) Medicament compositions based on tiotropium salts and on salmetrol salts
HK1102991A1 (en) Pharmaceutical formulation of decitabine
NO20031019D0 (no) Vedvarende frigivelsesformuleringer av oksymorfon
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
ATE355065T1 (de) Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika
WO2004112711A3 (en) Oral extended-release composition
SE0102276D0 (sv) Device and method for the administration of a medicament
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
CA2503810A1 (en) Therapeutic agent for fibromyalgia
WO2006072940A3 (en) Controlled long acting release pharmaceutical preparation for use in the oral cavity
SG148194A1 (en) Compositions for the treatment of affections of the oral cavity and upper respiratory tract
GB0130677D0 (en) Medicaments and novel compounds
EP1778209B8 (en) Methods and compositions for oral delivery of fts
WO2004026260A3 (en) Prophylactic and therapeutic hiv aptamers
WO2006079910A3 (en) 0-(3-piperidino-2hydroxypropyl)nicotinic amixodime for treating lesions in the oral cavity
SE0004101D0 (sv) New use
SE0200657D0 (sv) Novel Formulation
WO2001074396A8 (en) Composition and method for promoting oral health
MXPA04002401A (es) Nuevos medicamentos para inhalacion.
NZ542305A (en) Treatment of proliferative diseases with an epothilone derivative and radiation
WO2004073627A3 (en) Novel therapeutic method and compositions for topical administration